[1]
“Safety and Tolerability of Two Different Formulations of Mycophenolate (Mycophenolate Mofetil and Mycophenolate Sodium) among Patient with Connective Tissue Disease Associated Interstitial Lung Disease (CTD-ILD) in a Tertiary Care Hospital”, IJPHRD, vol. 11, no. 3, pp. 22–26, Mar. 2020, doi: 10.37506/ijphrd.v11i3.600.